Switches and naturals are high on Haleon’s agenda

3 March 2022 - Deborah Wilkes

Premium

Switching medicines from prescription to non-prescription status and launching naturals will be high on the agenda at GlaxoSmithKline (GSK) Consumer Healthcare following its demerger as Haleon in July 2022, says Brian McNamara, chief executive officer designate of Haleon.

Click tags below for more information on topics:

GlaxoSmithKline

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: